Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 29;10:8. doi: 10.1186/s13244-019-0690-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 10 — Hepatic focal lesion before and after TARE. a, b T2-WI shows an ill-defined HFL of an intermediate signal. c, d Subtracted enhanced T1-WI in the arterial phase shows early arterial heterogeneous enhancement. e, f Enhanced T1-WI in the delayed phase shows heterogenous washout. g, h After treatment, subtracted T1-WI arterial phase shows non-enhancement of the upper portion of the lesion with faint enhancement lower portion. i, j Delayed T1-WI shows delayed and persistent enhancement of the lesion due to massive fibrosis. Final diagnosis is LR-TR nonviable with post-therapy changes